|Arcus Ventures Fund II, 3/13||$35.6M|
Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting and private equity. AV is dedicated to investing in oncology focused companies with innovative biopharmaceuticals and or new drug delivery platforms in development, device companies with products that have pre-marketing approval, and service companies with positive revenue.
|Molecular Imaging||3/12||Series A||$9.9M||3|
|T2 Biosystems||8/11||Series D||$23M||10|
|MIR Acquisition||5/11||Series A||$7M||2|
|TRACON Pharmaceuticals||4/11||Series A||$14M||2|
|Vascular Pathways||11/10||Series B||$14M||4|
|T2 Biosystems||5/10||Series C||$15M||9|